Ladybon (Tibolone)

Tibolone is converted into metabolites that bind to estrogen, progesterone, and androgen receptors. This mixed hormonal activity provides estrogenic effects on bone and brain, progestogenic effects on the endometrium, and androgenic effects on peripheral tissues, collectively easing menopausal symptoms.

The dosage of Ladybon is determined by the prescribing clinician based on the individual’s medical condition, age, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Ladybon is not recommended for use during pregnancy or while breastfeeding because tibolone can affect hormonal balance. Women who are pregnant, planning to become pregnant, or nursing should discuss alternative treatments with their healthcare provider.

To order Ladybon, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Unlike traditional estrogen‑only or combined estrogen‑progestogen products, tibolone offers a unique triple‑action profile (estrogenic, progestogenic, androgenic). This can provide broader symptom relief and bone protection, but the safety profile differs, especially regarding thromboembolic risk, which should be evaluated against alternatives.

Ladybon should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Ladybon is taken orally, usually as a tablet, with or without food. The exact timing and frequency are set by the prescriber, and patients should swallow the tablet whole with water as directed.

The most serious risks include venous thromboembolism, severe hypertension, and liver dysfunction. Patients should be monitored for signs of blood clots, sudden high blood pressure, or abnormal liver tests, and seek immediate medical attention if these occur.

Ladybon is contraindicated in women with a history of breast or endometrial cancer, active liver disease, unexplained vaginal bleeding, or known thromboembolic disorders. It should also be avoided in pregnant or breastfeeding women.